Launched only 11 years after the creation of the NHS, MIMS has been at prescribers' sides for six decades of unprecedented changes in the landscape of medicines and healthcare.
The first edition of MIMS arrived during the early years of the antibiotic era and subsequent issues have supported prescribers through such other radical developments as the introduction of the contraceptive pill, the discovery of HIV and antiretroviral therapy and the advent of many classes of drugs that now form the backbone of primary care prescribing, including statins, beta-blockers and SSRIs.
Throughout this time MIMS has itself constantly evolved to meet prescribers' changing needs. Categorised by generic ingredient since 2008 to reflect best prescribing practice, the print edition became quarterly in 2014 and was streamlined earlier this year to focus on the drugs prescribers look up most often.
From fewer than 2000 drugs in 1959 MIMS has grown to provide concise listings for more than 3000 products. The drug database is available in full online, where it is updated constantly so prescribers can be confident they are always accessing the latest information.
MIMS has also expanded since its early days to offer an ever-increasing range of prescribing tools and resources, including drug comparison tables, quick-reference guideline summaries and visual guides to respiratory devices and diabetes devices. These are all available and updated constantly online.
Responding to a prescribing issue that has become increasingly problematic over the past year, MIMS recently introduced a live drug shortages tracker online to help primary care professionals avoid writing prescriptions for products that are out of stock.
Underlying all these changes, however, our mission remains constant: to be the most up-to-date, practical and easy-to-use prescribing tool for primary care professionals.
We hope to see you at our free to attend live education event, MIMS Learning Live, at Olympia London on Friday 28 June. Visit our stand to meet the editor, hear about the latest MIMS developments and tell us what you think about MIMS.
We also welcome your thoughts and feedback by email. Message us at email@example.com with your suggestions.